September 2013 Issue

Button: Follow us on Facebook! Button: Follow us on Twitter!

Button
ande
Satyanarayana Ande, PhD
Molecular Oncology and Biomarkers
Michael Benedict, PharmD
Associate Director of Administration
GRU_OncologyMugs_85P0737_ML
Department of Radiology
GRU_OncologyMugs_85P0809_ML
Department of Radiation Oncology
Picture Hasan Korkaya, DVM, PhD
Molecular Oncology and Biomarkers
Nita J. Maihle, PhD
Associate Director for Education
Mott Frank Mott, MD
Head and Neck
RSadek
Bioinformatics, Biostatistics and Computational Biology
Salman_Huda Huda Salman, MD, Hematology/Oncology
Claude Sportes
Claude Sportès, MD, Bone Marrow Transplant

The GRU Cancer Center is thrilled to launch its internal newsletter, the CC:Report.  The GRU Cancer Center Communications Team hopes you enjoy this premier issue and find it to be a helpful tool to assist, connect, and encourage you in your endeavors at the Cancer Center. Please contact Lisa Middleton (lmiddleton@gru.edu; x.14566) if you have information you would like to be considered for future editions.

A Time of growth and Change

Director's Corner: Samir N. Khleif, MD

“They always say time changes everything, but you actually have to change them yourself.”
– Andy Warhol

The GRU Cancer Center is undergoing an intense period of change. New staff, scientists and faculty have arrived. Others have departed. Growth is happening at an astonishing rate and the work we do and way we do it is evolving with each passing day. It’s an exciting time and an exciting process to be part of. And this is only the beginning. Read more >>

Have you Heard…?

Researcher’s Toolkit

Recent Publications
  • Postmenopausal Women, Obesity, and Breast Cancer Risk
     Using a simple urine test, researchers have identified a biomarker that may correlate with breast cancer risk in postmenopausal women.   Read more >>
  • Leukemia/Lymphoma – Toward a Better Prognosis
    GRU Cancer Center researchers have identified a potential treatment strategy for a rare but aggressive, largely incurable type of leukemia/lymphoma that is resistant to all current therapies. Read more >>
  • Improving Cancer Immunotherapy
    Researchers at the GRU Cancer Center have discovered a way to give the immune system a boost in its ability to recognize tumor cells as “enemy” agents. Read more >>
Grant News

Extramural

  • Satyanarayana Ande, PhD, received a $439K, 3-year K22 grant from NCI/NIH for “Role of Id1 in adiposity, energy balance and obesity associated liver tumorigenesis.”  Read more >>
  • Andrew Mellor, PhD, received a $1.5M, 4-year R01 grant from NIAID/NIH for “Engineering DNA nanoparticles to create immune tolerance.” Read more >>
  • Martha S. Tingen, PhD and Christine O’Meara, MA, MPH, received a $10K Wellness Mini-Grant from the University System of Georgia for “Promoting Wellness through Tobacco Cessation: A Component of the Tobacco-Free Campus Initiative at Georgia Regents University (GRU).” Read more >>
Intramural
  • Internal Translational Research Award Winners Read more >>
Newly Activated Clinical Trials
  • Olivier Rixe, PhD, MD: “Effect of 14-day repeated oral doses (500 mg) of SAR302503 on ventricular repolarization, compared to 1-day placebo, in adult patients with advanced solid tumors.” Read more >>
  • Shefali Shah, MD: “A Phase II study of docetaxel in combination with 1-methyl-D-tryptophan (indoximod) in metastic breast cancer.” Read more >>

About Jagwire

Jagwire is the official source for news and stories from Augusta University and AU Health. Daily updates highlight the many ways students, faculty, staff, researchers and clinicians "bring their A games" in classrooms and clinics on four campuses in Augusta and locations across the state of Georgia. Read on for stories of innovation in education and health care, opportunities at the center of Georgia’s new cybersecurity hub, and experiential learning that blends arts and application, humanities and the health sciences. Have a story to share with Jaguar Nation? Contact the Division of Communications & Marketing.